Logo-npj
ePublished: 01 Jan 2014
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Nephropharmacol. 2014;3(1): 3-4.
  Abstract View: 1202
  PDF Download: 1008

Epidemiology and Prevention

Vitamin D therapy in diabetic kidney disease

Mahmoud Rafieian-Kopaei 1, Hamid Nasri 2 *

1 Medical Plants Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran
2 Department of Nephrology, Division of Nephropathology, Isfahan University of Medical Sciences, Isfahan, Iran
*Corresponding author: Professor Hamid Nasri, Department of Nephrology, Division of Nephropathology, Isfahan University of Medical Sciences, Isfahan, Iran. Tel: +983112208081, Fax: +98311223 5043, hamidnasri@med.mui.ac.ir
Keywords: Vitamin D, Diabetic nephropathy, Renal failure

Implication for health policy/practice/research/medical education

Diabetic nephropathy is a major risk of end-stage kidney failure and is associated with greater morbidity and mortality, predominantly with augmented cardiovascular disease. Many complex factors relate to the progression of nephropathy of diabetic patients .Current investigations have focused on the optimization of renin-angiotensin system blockade in patients with diabetic nephropathy using combinations of drugs that target this pathway, however further studies have focused on the potential of new therapies that either target various pathways up-regulated by hyperglycemia or other targets believed to promote progression of diabetic nephropathy.

Please cite this paper as: Rafieian-Kopaei M, Nasri H. Vitamin D therapy in diabetic kidney disease. J Nephropharmacol 2014; 3(1): 3-4.

First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 1202

Your browser does not support the canvas element.


PDF Download: 1008

Your browser does not support the canvas element.